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Abstract—Relationship between a cell-free layer and wall
shear stress (WSS) in small arterioles has been of interest in
microcirculatory research. However, inﬂuence of temporal
variationinthecell-freelayerwidthontheWSSinvivohasnot
been fully elucidated. In this study, we tested the hypothesis
that the layer variation would increase the WSS, and this
effect would be enhanced by red blood cell aggregation. The
cell-free layer width in arterioles (29.5–67.1 lm ID) in rat
cremaster muscles were obtained with a high-speed video
camera, and the layer width data were introduced into WSS
estimation. Dextran 500 was administrated to elevate the
aggregation level of red blood cells to those seen in normal
human blood. The variation of the layer was quantiﬁed by the
variability (coefﬁcient of variation), and its effect on WSS was
studied under normal and reduced ﬂow conditions. We found
that the dextran-induced red blood cell aggregation signiﬁ-
cantly elevated the variability (p<0.01) at low pseudoshear
rates of 9.2 ± 0.6 s
21. The WSS estimated without taking
account of the variability showed underestimation of its value
thanthatofwithconsiderationofthevariabilityunderallﬂow
conditions, and this effect became more pronounced with
increasing the variability. The variation of the cell-free layer
should, therefore, be considered in the determination of the
WSS particularly in the presence of red blood cell aggregation
under reduced ﬂow condition.
Keywords—Wall shear stress, Cell-free layer, Hemodynam-
ics, Red blood cell aggregation.
INTRODUCTION
The arteriolar wall shear stress (WSS) has been of
interest as a dominant mechanical force in regulating
endothelial cell (EC) functions and vessel homeosta-
sis.
8,33 A signiﬁcant role of the WSS is to stimulate
release of endothelium-derived nitric oxide (NO) which
is a mediator of smooth muscle relaxation.
10,33 The
production rate of NO in general relies on the exposed
level of the WSS to ECs, and the relationship between
them was reported to be proportional.
13,26 In addition,
the oxygen release from arterioles appears to be related
to WSS since the latter was signiﬁcantly increased by a
reduction in oxygen concentration in the vessels.
6 Due
to its physiological importance, there have been a large
number of studies to estimate WSS in small vessels
both in vivo
2,22,29 and in vitro.
12,32 However, due to the
technical difﬁculties associated with WSS measurement
and complexity of the microvascular structure, in vivo
information of the WSS under various rheological
conditions has been very limited.
31
One of the prominent hemodynamic features in
microvascular blood ﬂow is the phase separation of red
blood cells and plasma, which leads to formation of a
cell-free layer adjacent to the endothelium in arterioles
and venules.
18,19 This phenomenon is being attributed
to the tendency of red blood cells and their aggregates
to migrate toward the vessel center.
9,19,24 Thus, the
cell-free layer formation can be inﬂuenced by a number
of rheological factors such as hematocrit, red blood
cell deformability, aggregability, vessel diameter, and
ﬂow rate.
24 In our previous study, we conﬁrmed that
the layer formation in arterioles can be enhanced by a
combination of red blood cell aggregation induction
and ﬂow reduction.
25
There are several physiological implications of the
cell-free layer. It could attenuate the ﬂow resistance in
microvessels by reducing friction between red blood
cells and ECs.
35,36 Alternatively, the layer may become
a diffusion barrier for oxygen transport to tissues or
reduce the scavenging of NO by red blood cells.
5,7,21
The cell-free layer exhibits dynamic changes in its
width, and previous studies have shown that it is
important to consider such variation in the layer
as it may alter the effective magnitude of WSS
response.
18,34 Temporal changes in the cell-free layer
width were evident from previous studies that were
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359performed to simulate physiological and pathophysi-
ological states of red blood cell aggregation.
18,25 An
increase in red blood cell aggregation coupled with a
reduction in ﬂow under pathophysiological conditions
was found to result in a more irregular interface
between the red blood cell core and cell-free layer,
providing evidence of greater layer variation under
rheological abnormalities.
25 While the cell-free layer
itself is capable of attenuating WSS by lowering
effective blood viscosity, the variation in the layer
could potentially offset this effect by a certain extent
through augmenting the WSS and this effect may be
more pronounced under pathophysiological condi-
tions.
34 Such modulation of WSS in microvessels could
also be a critical determinant of EC response to blood
ﬂow since these cells are highly sensitive to microscale
subcellular shear stress distribution.
3 Despite the con-
siderable physiological implications that the cell-free
layer can impose through WSS changes in microvas-
cular ﬂow, in vivo quantitative information on how the
layer variation can affect the WSS has not been
available.
As the cell-free layer characteristics are dependent
on red blood cell aggregation, the ﬁrst part of this
study was carried out to provide information on how
this blood rheological property could aﬀect the layer
variation. We then examined how such changes in
layer variation could inﬂuence the WSS in vivo.W e
hypothesized that the layer variation would induce an
increase in WSS and this effect would be enhanced by
red blood cell aggregation. A new method of approx-
imating the WSS in vivo was proposed and validated by
an in vitro microtube system. The rat cremaster muscle
was exteriorized for visualization of the cell-free layer
formation in arteriolar blood ﬂow, and Dextran 500
was used to induce red blood cell aggregation in the
rat. In addition, our recently developed image analysis
method
16 was employed to provide detailed temporal
information of the cell-free layer under different rhe-
ological conditions in the arterioles.
MATERIALS AND METHODS
Animal Preparation
Animal handling procedures were provided
according to the Guide for the Care and Use of Lab-
oratory Animals (Institute for Laboratory Animal
Research, National Research Council, Washington,
DC: National Academy Press, 1996) and approved by
the local Animal Subjects Committee. A total of 12
arterioles in the cremaster muscles from Wistar-Furth
rats (202.8 ± 18.5 g) were used in this study. The
animal was placed on a heating pad to maintain body
temperature at 37  C during surgery, and a tracheal
tube was inserted to assist ventilation. The femoral
artery was catheterized for blood withdrawals and
pressure measurements, whereas the jugular vein was
catheterized for administration of anesthetic, Dextran
500 (average molecular mass of 460 kDa; Sigma) dis-
solved in saline (6%), and other solutions. The rat
cremaster muscle was exteriorized and prepared for
intravital microscopy. An in vivo metrics 1.5 mm ID
pneumatic cuff was placed on the abdominal aorta to
adjust arterial pressure to the muscle. A heating ele-
ment maintained the muscle temperature at 35  C
during the entire experiment. The detailed descriptions
on the animal preparation have been reported in our
earlier studies.
15,18
Hematocrit, Aggregation, and Arterial Pressure
Measurements
The hematocrit was measured with a microhemat-
ocrit centrifuge (Readacrit, Clay Adams) and aggre-
gation level of red blood cell was determined with an
aggregometer (Myrenne aggregometer; Myrenne,
Roetagen, Germany) periodically during the experi-
ments. A physiological data-acquisition system (MP
100 System; BIOPAC Systems, Goleta, CA) was used
to monitor arterial pressure in the femoral artery.
Experimental Protocol
An unbranched region was selected for the study
based on stable ﬂow, clear focus, and contrast of the
image. An intravital microscope (Ortholux II, Leitz)
was used with a water-immersion objective (409,
Olympus) and a long working distance condenser
(Instec, Boulder, CO), which has numerical apertures
of 0.7 and 0.35, respectively. A blue ﬁlter (Spectra
Physics, no. 59820) with peak transmission at 400 nm
and spectral bandpass of 300–500 nm was used to
enhance the contrast between red blood cells and the
background ﬁeld. The blood ﬂow was recorded at
1125–4500 frames/s with a high-speed video camera
(FASTCOM ultima SE, Photron USA) for 1–4 s,
depending on the ﬂow rate in the vessel.
In this study, we obtained data from 4500 frames
for all conditions, at normal and reduced arterial
pressures before and after dextran infusion. The
pneumatic cuﬀ pressure was increased with an air-ﬁlled
syringe to lower the femoral artery pressure to
~50 mmHg and maintained by manual adjustment.
Dextran 500 was used to induce red blood cell aggre-
gation. A total of 200 mg/kg body wt was infused over
the time course of 1–2 min to achieve an estimated
plasma dextran concentration of ~0.6%. Our previous
studies
17,18 reported that this concentration of Dextran
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normal human blood. After dextran treatment, an
additional blood sample was taken to determine
hematocrit and aggregation level.
Pseudoshear Rate Determination
The edge velocity of the red blood cell core was
determined by tracking movements of outermost cells
manually across 10 digital frames using image analy-
sis software (SigmaScan Pro 5). The pseudoshear rate
  c ðÞused in this study was deﬁned as follows:
  c ¼
Vedge
D
ð1Þ
where Vedge is the mean edge velocity of red blood cell
core and D is the vessel diameter.
Cell-Free Layer Width and Its Variability
The cell-free layer width at a speciﬁc location was
determined from the positions of the inner vessel wall
and the outer edge of the red blood cell core. A typical
example of the variation in the layer width is shown in
the lower part of Fig. 1. The detailed image analysis
method to determine the width of the layer is available
in our earlier reports.
16,18 To quantify the layer vari-
ation, the statistical concept of coefﬁcient of variation
(variability) was employed, which represents the ratio
of the standard deviation of the layer width to its
mean.
Wall Shear Stress Estimation
In estimation of the WSS, we assumed that the
plasma ﬂow in the cell-free layer is steady and the
velocity gradient in the layer is linear. Thus, the WSS
(s) could be estimated with the plasma viscosity and
slope of the linear velocity proﬁle as follows:
s ¼ l
Vedge
W
ð2Þ
where l is the plasma viscosity and W is the cell-free
layer width. The dextran treatment increases plasma
viscosity as well as level of red blood cell aggrega-
tion.
20,28,39 However, in our in vivo study, the plasma
viscosity effect on the WSS was isolated by using the
same plasma viscosity value (1.3 cP)
37 in determination
of the WSS for all conditions. As shown in the upper
part of Fig. 1, using Eq. (2), the WSS is inversely
related to the cell-free layer width. The WSS (s*) under
the inﬂuence of the temporal variation in the layer
width was obtained by averaging the individual WSS
(si) derived from each value of the layer width (Eq. (3))
at respective times. The result was then compared to
that obtained without consideration of the variation in
the layer width. For the latter, the cell-free layer widths
over 4500 frames were averaged and the resultant
mean width was used to estimate the WSS (Eq. (4)). In
Eqs. (3)a n d( 4), i denotes a frame number.
si ¼ l
Vedge
Wi
s  ¼ 1
n
P n
i¼1
si
2
6 4 i ¼ 1;2;3;...;n ¼ 4500 ðÞ ð 3Þ
s ¼ l
Vedge
1
n
P n
i¼1
Wi
i ¼ 1;2;3;...;n ¼ 4500 ðÞ ð 4Þ
In Vitro Setup
We constructed an in vitro microtube system to test
our hypothesis that WSS may be estimated from the
cell-free layer width and plasma viscosity (Eq. (3)). The
inner diameter of each glass microtube (Polymicro
Technologies, Phoenix, USA) was determined from
pressure-ﬂow measurements with distilled water while
the length of the tube was measured with the vernier
caliper. The inner diameter and length were 50–52 lm
and 55–60 mm, respectively. The ratio of length to
inner diameter was over 1000:1 so that pressure drops
in other parts of the system could be neglected.
Reﬂective index (RI) of the glass tubes (fused silica)
was 1.45 for the halogen light spectrum from 650 to
1050 nm and the tubes were immersed in kerosene
(RI = 1.45) during blood ﬂow visualization to mini-
mize measurement error for the cell-free layer width,
which could be caused by the common RI problem
in circular tubes. Heparinized rat blood samples
were obtained from donor rats, and all the measure-
ments were completed within 1 h after blood
FIGURE 1. Relationship between the cell-free layer (CFL)
width and wall shear stress (WSS). The solid and dotted lines
represent the WSS and CFL width obtained in an arteriole
(50 lm ID), respectively. Only 100 data selected from 4500
frames are shown here.
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were compared with those calculated using Eq. (5)
shown below with pressure drop information obtained
with the differential pressure transducer (MP 100
System, CA, USA) and a syringe pump (Harvard
Apparatus, MA, USA). The plasma viscosity was
determined with a cone-and-plate viscometer (Brook-
ﬁeld Engineering Laboratories, Inc., MA, USA)
s ¼
DP   D
4L
ð5Þ
where DP is the pressure difference between inlet and
outlet of the microtube and L and D are the length and
inner diameter of the microtube, respectively.
Statistical Analysis
Astatisticalsoftwarepackage(Prism4.0,GraphPad)
was used for all statistical analyses. An unpaired t-test
was utilized to compare two groups before and after
dextrantreatmentwhilelinearandnonlinearregressions
wereperformedtoﬁndasigniﬁcantrelationbetweenthe
two parameters. All physiological and rheological val-
ues are represented as means ± SD. For all tests,
p<0.05 was considered to be statistically signiﬁcant.
RESULTS
In Vitro Validation
As shown in Fig. 2, the WSS estimated from the
cell-free layer width and plasma viscosity agreed within
±20% with that determined with the pressure drop
measurements, and R
2 value for the linear regression
was 0.76. The error range was similar to that reported
with the l-PIV method by Long et al.
23 using ﬂuo-
rescent nano-particles. The pseudoshear rate range
used for this comparative study was 130–290 s
21. The
good agreement of the WSS estimated from the cell-
free layer method with that determined by the con-
ventional pressure drop measurement indicates that
the cell-free layer method has promise for in vivo use
and thus may provide valuable new information where
it is currently lacking.
Systemic Values in In Vivo Experiments
Control arterial pressure was 112 ± 13.7 and 108 ±
4.7 mmHg before and after dextran treatment,
respectively. After arterial pressure reduction, the
pressure fell to 47 ± 7.9 and 47 ± 5.5 mmHg in nor-
mal and dextran-treated rats, respectively. For both
control and reduced pressure cases, there was no sig-
niﬁcant diﬀerence between the two pressure values
before and after dextran treatment. The index of red
blood cell aggregation (M) determined by the Myrenne
aggregometer was 0.0 (no aggregation) before dextran
treatment, whereas it increased to 9.9 ± 1.4 after
dextran treatment, which is similar to levels found in
normal human blood.
17,18 Systemic hematocrit was
39 ± 1.8% and 38 ± 1.0% before and after dextran
treatment, respectively, with no signiﬁcant changes.
The diameter range of arterioles used in this study was
29.5–67.1 lm.
Cell-Free Layer Characteristics
Pseudoshear rate in arterioles at normal arterial
pressure was 187.9 ± 52.5 and 177.4 ± 32.8 s
21 before
and after dextran treatment. After reduction of arterial
pressure, the pseudoshear rate dropped to 34.0 ± 19.9
and31.5 ± 18.4 s
21beforeandafterdextrantreatment,
respectively. Our recent study
25 with similar pressure
reduction to that in this study reported that ﬂow
velocity in arterioles might be nonuniformly reduced by
the arterial pressure drop. Thus, to examine red blood
cell aggregation effect on the cell-free layer variability,
we divided all the data into three different pseudoshear
rate groups based on their mean values (<10 s
21,
>40 s
21,a n d<60 s
21, >100 s
21). Thus cell-free layer
data were grouped into three ﬂow conditions, at
182.8 ± 43.8, 47.9 ± 3.0, and 9.2 ± 0.6 s
21. There was
nosigniﬁcanteffectofdextrantreatmentonthecell-free
layer variability (Fig. 3) at relatively high pseudoshear
rates (182.8 ± 43.8 and 47.9 ± 3.0 s
21), whereas red
blood cell aggregation signiﬁcantly increased the layer
variability (p<0.01) at 9.2 ± 0.6 s
21.
FIGURE 2. In vitro validation of the WSS estimation with the
cell-free layer width and plasma viscosity. The solid line rep-
resentsthelinearregressionﬁt(y 5 0.984x + 0.014;R
2 5 0.76)
for the combined group of three different conditions (s: with-
out dextran treatment at 30% hematocrit, D: with dextran
treatment at 30%, and h: without dextran treatment at 35%).
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Figure 4 shows the ratio of the WSS with consid-
eration of the variation in the cell-free layer (s*) to that
when there is no variation in the layer width (s). The
ratio was higher than 1.0 regardless of pseudoshear
rates and increased with an elevation of the variability
at all pseudoshear rates. Furthermore, this effect
became more pronounced at low shear rates based on
the larger coefﬁcient (B2) that describes the steepness
of the ﬁtted curve. There was a slight shift in range of
the layer variability from 0.26–0.67 to 0.34–0.81 after
dextran treatment, which is not surprising according to
the ﬁndings shown in Fig. 3.
DISCUSSION
The salient ﬁnding of this study is that cell-free layer
variability in the arterioles was signiﬁcantly augmented
by aggregation induction at reduced ﬂow rates, which
in turn could potentially lead to an enhancement of
WSS in the arterioles.
Limitations in WSS Approximation
In this study, the averaged edge velocity of red
blood cell core was used in estimation of the WSS
although blood ﬂow might still be unsteady in arteri-
oles.
27,38 We have previously pointed out that during
the cardiac cycle, the edge velocity of the red blood cell
core at normal arterial pressure might vary by ±6–7%
from the mean value.
18 Therefore, by considering the
pulsatile nature of the arteriolar ﬂow, the actual vari-
ation of the WSS may differ from our estimation by a
maximum of 6–7%. However, under reduced ﬂow
conditions, the ﬂow pulsatility would be much lower
than that in normal ﬂow conditions. Thus, effects of
the unsteady ﬂow on the WSS estimation in low shear
conditions may not be as signiﬁcant. The spatial res-
olution of the cell-free layer width measurement with
the current microscope system was reported to be
~0.4 lm,
18,25 which limits the accuracy of our WSS
estimation since one of the key parameters in Eq. (2)
determining the WSS is the width of the cell-free layer.
Thus, variability in the layer width smaller than the
systemic spatial resolution cannot be detected with the
current system.
FIGURE 3. Effect of red blood cell aggregation on variability
of the cell-free layer. h: Before dextran infusion. j: After
dextran infusion. * p<0.01.
FIGURE 4. Ratio between estimated WSS values with (s*)
and without (s) consideration of variations in the cell-free
layer width as a function of the layer variability. The nonlinear
regression was performed with a quadratic function (y 5
B0 + B1x + B2x
2, where B0 is 1) for the combined group (before
(s) and after (d) dextran treatment). y 5 1 2 0.07x + 1.64x
2;
R
2 5 0.76 at 182.8 6 43.8 s
21. y 5 1 2 0.36x + 2.31x
2; R
2 5
0.88 at 47.9 6 3.0 s
21. y 5 1 2 0.52x + 2.77x
2; R
2 5 0.77 at
9.2 6 0.6 s
21.
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A number of studies have provided information on
arteriolar WSS in a variety of species and tissues. The
WSS in resting cat sartorius muscle arterioles (~60 lm
ID) was estimated to be ~6 Pa with bulk viscosity of
blood at 45% hematocrit.
27 A previous study carried
out with the rat cremaster muscle estimated the WSS
to be approximately 1.0–4.5 Pa in larger arterioles
(160–220 lm ID) using 3.8 cP of blood viscosity.
2 In a
recent review by Reneman and Hoeks,
31 the WSS in
mesenteric arterioles was found to be 0.51–5.0 Pa in
rabbits and 4.71 ± 2.34 Pa in cats. Pries and cowork-
ers
30 reported that the WSS of ~5 Pa with a substantial
variation observed in rat mesenteric arterioles
(>15 lm ID). In this study, the mean arteriolar WSS
varied from ~0.3 to 7.5 Pa under normal and reduced
ﬂow conditions, which is in agreement with the range
of values reported in previous studies. However, since
the WSS is a function of several rheological condi-
tions such as vessel size, viscosity, and ﬂow velocity, it
may not be feasible to directly compare the WSS
values under different physiological and rheological
situations.
Eﬀect of Aggregation on Cell-Free Layer Variability
and WSS
As shown in Fig. 3, the variability of the cell-free
layer signiﬁcantly (p<0.01) increased after dextran
treatment only at 9.2 ± 0.6 s
21, which was reﬂected in
a shift of the variability range toward higher magni-
tudes after dextran infusion in Fig. 4c. Although there
were no statistical differences in the variability before
and after dextran treatment at the other two shear
rates (182.8 ± 43.8 and 47.9 ± 3.0 s
21), it appeared to
be consistent that the variability increased after dex-
tran treatment. These ﬁndings were in consensus with
those reported in previous in vitro
1 and in vivo stud-
ies
18,25 performed in narrow vertical tubes (28–101 lm
ID) perfused with human blood and in arterioles in rat
cremaster muscle (10–60 lm ID), respectively. The
results in this study imply that red blood cell aggre-
gation may play a major role in altering the cell-free
layer variability, in particular at regions of blood ﬂow
characterized by low pseudoshear rates (<10 s
21).
Similarly, our earlier in vivo studies
18,25 have substan-
tiated that apparent changes in cell-free layer charac-
teristics under similar aggregating conditions are only
observed at low pseudoshear rates (<50 s
21). It should
be noted that pseudoshear rates used in this study were
based on the ﬂow velocity near the vessel wall, whose
magnitude would be less than that of mean cellular
velocity. Therefore, for the same ﬂow conditions, the
pseudoshear rates reported here should be smaller than
those in previous studies, which were based on the
mean cellular velocity.
As shown in Fig. 4, the layer variability ranged
approximately from 0.2 to 0.6 even without dextran
induction under similar ﬂow conditions. It should be
noted that the variability data were obtained from 12
arterioles which can have different local hematocrits.
Furthermore, it is well known that local hematocrits
can take on a wide range of values even for vessels of
the same order in the same arteriolar network.
11 Since
cell-free layer characteristics are dependent on hemat-
ocrit, it is expected that the cell-free layer can exhibit a
wide range of variability between similar diameter
vessels even in the absence of red blood cell aggrega-
tion and/or under similar ﬂow conditions.
The results shown in Fig. 4 suggest that the vari-
ability of the cell-free layer can be an important
parameter which causes an elevation of the WSS,
particularly at low pseudoshear rates where red blood
cell aggregation could enhance the layer variability. In
a computational study by Sharan and Popel,
34 they
showed that the effective blood viscosity near the vessel
wall increased with greater interface roughness
between red blood cell core and the cell-free layer in
vessel ranges of 25–70 lm at 45% hematocrit. Their
ﬁnding is qualitatively in agreement to that in this
study, as an increased effective viscosity would lead to
an augmentation in WSS. Therefore, we emphasize
here the importance of considering the cell-free layer
variation in WSS determination which otherwise could
result in an underestimation of the WSS, by as much as
two folds, with high variability (~0.7) observed under
aggregating condition at 9.2 ± 0.6 s
21 (see Fig. 4).
Figures 5a and 5b represent respective conceptual
sketches of ﬂowing red blood cells in a vessel illustrat-
ing the effect of temporal variation in the cell-free layer
on WSS. We compared the two cases (Figs. 5aa n d5b)
with the same mean width of the cell-free layer. When
the WSS was obtained from blood ﬂow with no varia-
tion in the cell-free layer width (Fig. 5b), the mean WSS
could be lower than that in the situation with variation
in the layer width (Fig. 5a). Our previous studies
18,25
have shown that a wider cell-free layer would allow a
higher degree of variability of the layer and vice versa.
In the event where the magnitude of WSS is small due
to a thick cell-free layer, the corresponding large vari-
ability in the layer may partially compensate the effect
of the thick layer on the WSS. It should be further
noted that for there to be no change in the WSS on the
average, individual cell-free layer width data should be
symmetrically distributed about their mean value. As
shown by our previous study,
25 the layer width data
follow a non-Gaussian distribution and, therefore, are
not symmetrical about their mean value; hence, a
change in the WSS on the average is expected.
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The inverse relationship between the cell-free layer
width and the WSS suggests that NO production could
be inevitably aﬀected by the layer formation since WSS
is a mechanical stimulus for endothelium-derived NO
synthesis. However, overall NO bioavailability that
ultimately inﬂuences vascular tone would also be
dependent on other physiological aspects associated
with the layer. The cell-free layer could act as a diﬀu-
sion barrier that could potentially minimize NO scav-
enging by the red blood cells.
5,14,21 In addition, we
presented here the possibility of cell-free layer vari-
ability to improve NO preservation by enhancing the
WSS. All of these factors may contribute to the local
regulatory mechanism of vasodilation. In normal ﬂow
conditions, it is likely that the WSS can sufﬁciently
stimulate the production of NO in the endothelium, in
a way that could cancel out any potential scavenging
effect of NO by the red blood cells. On the contrary, in
low ﬂow conditions, the diminishing magnitude of the
WSS acting on the endothelium due to the effects of
lower hydrodynamic forces and more prominent cell-
free layer formation in the presence of aggregation can
attenuate NO production. It has been demonstrated
that enhanced red blood cell aggregation in suspen-
sions used for perfusion of glass capillaries led to the
down-regulation of NO synthesizing mechanisms in
human umbilical vein ECs coating the capillaries.
40
In vivo studies have also supported this ﬁnding.
4
In contrast, our ﬁndings would suggest that an
enhanced layer variability due to aggregation induc-
tion could oppose the above response on endothelial
NO production by augmenting the WSS. It should be
noted that this variability effect might be offset by
reduction of WSS due to the thicker cell-free layer.
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